Dec 2017

Navitas brings End – to – End R&D Solutions to the Generic Drug Industry

Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver “first to file” results to generic drug companies around the globe,...

Sep 2017

Navitas Life Sciences, a TAKE Solutions Enterprise, has been named as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment

Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and an end-to-end provider of transformative solutions across the spectrum of Clinical, Regulatory and Safety in Life Sciences announced,...

Jul 2017

From fifteen to future – Navitas Networks 15 year anniversary

Navitas transformed the iconic Carnegie Hall as we celebrated 15 years of our unique, industry leading Networks and hosted 85 industry leaders from a range of pharmaceutical companies,...

Jun 2017

Life Sciences expert Navitas augments end-to-end capabilities

Navitas, a technology-led Life Sciences services provider across Clinical, Regulatory and Safety, announced that it would be augmenting its capabilities with the niche expertise of its legacy brands,...

Apr 2017

ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and Subsequent Renovation of ICH E6 January 2017

Navitas welcomes the opportunity to provide comments on this Reflection Paper...

Apr 2017

Navitas Life Sciences Augments Global Executive Management Team

Navitas Life Sciences announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer. As the Chief Growth Officer, Krishnan will oversee Navitas’ sales and marketing efforts,...

Jan 2017

Navitas Networks announce Forum dates for Spring, 2017

The Navitas Networks are pleased to confirm the dates for our upcoming Spring forums...

Jan 2017

Navitas Launches Labeling Assessment Express

Regulators are changing the way they look at labeling. The emphasis is on ensuring Marketing Authorization Holders have a linked up End-to-End (E2E) process...

Latest News & Articles


Encouraging patient-centric innovation in pharma

Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions...


Barriers Preventing Clinical Trial Software Development

Back in August of 2011 in the Wall Street Journal, Marc Andressen, the...